- High on-treatment platelet reactivity: risk factors and 5-year outcomes in patients with acute myocardial infarction2017 | Faculty of Medicine in Hradec Králové
- Selection of P2Y12 antagonist, treatment initiation, and predictors of high on-treatment platelet reactivity in a "Real World" registry2015 | Third Faculty of Medicine
- Clopidogrel up-titration versus standard dose in patients with high residual platelet reactivity after percutaneous coronary intervention: A single-center pilot randomised study2011 | Third Faculty of Medicine
- Role of Dipyrone in the High On-Treatment Platelet Reactivity amongst Acetylsalicylic Acid-Treated Patients Undergoing Peripheral Artery Revascularisation2018 | First Faculty of Medicine
- The relationship between mean platelet volume and high on-treatment platelet reactivity Reply2014 | Faculty of Medicine in Hradec Králové
- Severe Left Ventricular Systolic Dysfunction is Independently Associated with High On-Clopidogrel Platelet Reactivity2014 | Third Faculty of Medicine
- Mean platelet volume and platelet count: overlooked markers of high on-treatment platelet reactivity and worse outcome in patients with acute coronary syndrome2014 | Faculty of Medicine in Hradec Králové
- High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial2009 | First Faculty of Medicine, Third Faculty of Medicine
- High leukocyte count and interleukin-10 predict high on-treatment-platelet-reactivity in patients treated with clopidogrel2012 | Third Faculty of Medicine
- CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in prasugrel- or ticagrelor-treated STEMI patients: monocentric study in PRAGUE-18 trial participants2020 | Third Faculty of Medicine
- Acetylosalicylic acid efficacy assessment in patients with stable coronary artery disease2011 | Faculty of Medicine in Hradec Králové
- Pharmacodynamic effect of clopidogrel in patients undergoing transcatheter aortic valve implantation2013 | Third Faculty of Medicine
- Safety and Efficacy of Cangrelor, an Intravenous, Short-Acting Platelet Inhibitor in Patients Requiring Coronary Artery Bypass Surgery2013 | Publication without faculty affiliation
- Opacification of a hydrophilic acrylic intraocular lens with a hydrophobic surface after air injection in Descemet-stripping automated endothelial keratoplasty in a patient with Fuchs dystrophy2016 | Third Faculty of Medicine, Central Library of Charles University
- Efficacy of P2Y12 receptor antagonists in patients with atrial fibrillation according to the CHA2DS2VASc score2016 | Third Faculty of Medicine
- The clinical importance of antiplatelet resistance and its potential solution2012 | Faculty of Medicine in Pilsen
- Anti-platelet treatment: switching from clopidogrel to prasugrel2012 | Publication without faculty affiliation
- High-residual platelet activity despite dual antiplatelet treatment associated with subacute stent thrombosis2009 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Good short-term but not long-term reproducibility of the antiplatelet efficacy laboratory assessment2012 | Faculty of Medicine in Hradec Králové
- Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectiveness2010 | First Faculty of Medicine, Third Faculty of Medicine
- Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "Paradox"2009 | First Faculty of Medicine, Third Faculty of Medicine
- The Impact of Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies with and without Apheresis on Platelet Aggregation in Familial Hypercholesterolemia2024 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Thrombosis - the central problem in clinical cardiology2013 | Third Faculty of Medicine
- Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction2016 | Third Faculty of Medicine, Faculty of Mathematics and Physics
- Antiplatelet effect of prasugrel and clopidogrel in hypothermic patients after cardiac arrest for acute myocardial infarction2014 | Third Faculty of Medicine, Faculty of Mathematics and Physics
- Stent Thrombosis After ACS-PCI: Does Adherence to Antiplatelet Therapy Involve More Than Its Intensity?2019 | Third Faculty of Medicine
- Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery A Randomized Controlled Trial2012 | Publication without faculty affiliation
- Impact of CYP2C19 Polymorphisms on Clinical Outcomes and Antiplatelet Potency of Clopidogrel in Caucasian Poststroke Survivors2018 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?2022 | First Faculty of Medicine